Citadel Advisors’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
+33,700
New +$1.85M ﹤0.01% 6486
2026
Q1
Sell
-19,800
Closed -$760K 14469
2025
Q4
$760K Buy
19,800
+4,400
+29% +$150K ﹤0.01% 8024
2025
Q3
$518K Buy
15,400
+3,900
+34% +$141K ﹤0.01% 9045
2025
Q2
$454K Buy
11,500
+9,500
+475% +$395K ﹤0.01% 8869
2025
Q1
$70.6K Buy
2,000
+1,100
+122% +$38.3K ﹤0.01% 11900
2024
Q4
$28.1K Sell
900
-1,500
-63% -$42K ﹤0.01% 12931
2024
Q3
$56.7K Sell
2,400
-600
-20% -$13.4K ﹤0.01% 11771
2024
Q2
$60K Buy
+3,000
New +$59K ﹤0.01% 11561

Other funds holding MRX

Citadel Advisors's MRX Position: Q2 2026 in Review

Citadel Advisors sold out of Marex Group Limited Ordinary Shares (MRX) in Q2 2026, closing a stake of 173,474 shares — an estimated $9.55M sold.

Citadel Advisors first reported a position in MRX in Q2 2024 and held it in 8 quarters. The position peaked at $38.7M in Q2 2025. 221 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

  • Citadel Advisors reported no remaining Marex Group Limited Ordinary Shares position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 173,474 Marex Group Limited Ordinary Shares shares in Q2 2026, an estimated $9.55M.
  • Citadel Advisors first reported a position in Marex Group Limited Ordinary Shares in Q2 2024 and held it in 8 quarters.
  • Citadel Advisors's Marex Group Limited Ordinary Shares position peaked at $38.7M in Q2 2025.
  • 221 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.